Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cAMP-dependent protein kinase activity	PRKACA PRKACG	1.85e-04	7	60	2	GO:0004691
GeneOntologyMolecularFunction	cyclic nucleotide-dependent protein kinase activity	PRKACA PRKACG	3.15e-04	9	60	2	GO:0004690
GeneOntologyMolecularFunction	AMP-activated protein kinase activity	PRKACA PRKACG	3.93e-04	10	60	2	GO:0004679
GeneOntologyBiologicalProcess	protein-DNA complex organization	ZNF462 HDAC9 GLMN MBTD1 SMCHD1 SUPT16H ERCC6L2 AHR TEX15 IFI16 USP16 HP1BP3	2.12e-05	999	59	12	GO:0071824
GeneOntologyBiologicalProcess	chromatin organization	ZNF462 HDAC9 GLMN MBTD1 SMCHD1 SUPT16H ERCC6L2 TEX15 IFI16 USP16 HP1BP3	4.04e-05	896	59	11	GO:0006325
Domain	TPR-like_helical_dom	APPBP2 SAMD9 TRANK1 WDR35 CSTF3	7.15e-04	233	57	5	IPR011990
Domain	Cyclin_N	CABLES2 CCNB1	4.55e-03	33	57	2	IPR006671
Domain	Cyclin_N	CABLES2 CCNB1	4.55e-03	33	57	2	PF00134
Domain	CYCLIN	CABLES2 CCNB1	6.00e-03	38	57	2	SM00385
Domain	-	CABLES2 CCNB1	6.63e-03	40	57	2	1.10.472.10
Domain	-	SAMD9 TRANK1 MCM8 ERCC6L2 GNAT3 ABCC11 DNAH14	7.35e-03	746	57	7	3.40.50.300
Domain	Cyclin-like	CABLES2 CCNB1	7.63e-03	43	57	2	IPR013763
Pathway	KEGG_TASTE_TRANSDUCTION	TAS2R13 PRKACA PRKACG GNAT3	2.40e-05	52	46	4	M5785
Pathway	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS	PRKACA PRKACG	1.04e-04	5	46	2	M26988
Pathway	WP_CANNABINOID_RECEPTOR_SIGNALING	PRKACA PRKACG AHR	1.12e-04	29	46	3	M39676
Pathway	KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME	PRKACA PRKACG	2.16e-04	7	46	2	M47896
Pathway	REACTOME_HDL_ASSEMBLY	PRKACA PRKACG	2.88e-04	8	46	2	M27840
Pathway	REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION	PRKACA PRKACG GNAT3	3.66e-04	43	46	3	M29837
Pathway	REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION	MCM8 CCNB1	3.70e-04	9	46	2	M5756
Pathway	REACTOME_ROBO_RECEPTORS_BIND_AKAP5	PRKACA PRKACG	3.70e-04	9	46	2	M27877
Pathway	REACTOME_GPER1_SIGNALING	PRKACA PRKACG GNAT3	4.19e-04	45	46	3	M45008
Pathway	KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY	PRKACA PRKACG	4.61e-04	10	46	2	M47648
Pathway	BIOCARTA_AKAP95_PATHWAY	PRKACG CCNB1	5.62e-04	11	46	2	M5731
Pathway	REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM	PRKACA PRKACG	6.73e-04	12	46	2	M27950
Pathway	REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE	PRKACA PRKACG	6.73e-04	12	46	2	M27363
Pathway	REACTOME_G_PROTEIN_MEDIATED_EVENTS	PRKACA PRKACG GNAT3	7.18e-04	54	46	3	M26911
Pathway	KEGG_VIBRIO_CHOLERAE_INFECTION	ATP6V0A4 PRKACA PRKACG	7.18e-04	54	46	3	M17906
Pathway	WP_MRNA_PROCESSING	PTBP2 RBM5 CSTF3 SNRPB2	7.43e-04	126	46	4	M39406
Pathway	REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME	NCOR2 PRKACA	7.94e-04	13	46	2	M29766
Pathway	WP_DOPAMINE_METABOLISM	PRKACA PRKACG	7.94e-04	13	46	2	M39622
Pathway	KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY	PRKACA PRKACG	1.06e-03	15	46	2	M47794
Pathway	KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY	PRKACA PRKACG	1.06e-03	15	46	2	M47504
Pathway	KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY	PRKACA PRKACG	1.21e-03	16	46	2	M47551
Pathway	KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY	PRKACA PRKACG	1.21e-03	16	46	2	M47645
Pathway	KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY	PRKACA PRKACG	1.21e-03	16	46	2	M47650
Pathway	REACTOME_RAP1_SIGNALLING	PRKACA PRKACG	1.21e-03	16	46	2	M923
Pathway	PID_HDAC_CLASSI_PATHWAY	HDAC9 NCOR2 PRKACA	1.29e-03	66	46	3	M101
Pathway	REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING	PRKACA PRKACG	1.37e-03	17	46	2	M26995
Pathway	KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY	PRKACA PRKACG	1.37e-03	17	46	2	M47544
Pubmed	Delta-like 1 contributes to cell growth by increasing the interferon-inducible protein 16 expression in hepatocellular carcinoma.	DLK1 IFI16	2.93e-06	2	60	2	20214740
Pubmed	Characterization of the cAMP-dependent protein kinase catalytic subunit Cgamma expressed and purified from sf9 cells.	PRKACA PRKACG	2.93e-06	2	60	2	15039079
Pubmed	The design of coiled-coil structures and assemblies.	CCDC74A CCDC168	2.93e-06	2	60	2	15837514
Pubmed	Retinoids repress Ah receptor CYP1A1 induction pathway through the SMRT corepressor.	NCOR2 AHR	2.93e-06	2	60	2	15325265
Pubmed	Molecular cloning of a tissue-specific protein kinase (C gamma) from human testis--representing a third isoform for the catalytic subunit of cAMP-dependent protein kinase.	PRKACA PRKACG	8.77e-06	3	60	2	2342480
Pubmed	Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein.	PRKACA PRKACG	8.77e-06	3	60	2	12842892
Pubmed	Coiled coils: a highly versatile protein folding motif.	CCDC74A CCDC168	8.77e-06	3	60	2	11166216
Pubmed	Protein kinase A regulates cell cycle progression of mouse fertilized eggs by means of MPF.	PRKACA CCNB1	8.77e-06	3	60	2	15580572
Pubmed	The aryl hydrocarbon receptor activates the retinoic acid receptoralpha through SMRT antagonism.	NCOR2 AHR	8.77e-06	3	60	2	16480812
Pubmed	The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.	PRKACA PRKACG	8.77e-06	3	60	2	19383776
Pubmed	Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.	PPP1R2 PHKA2 CABLES2 PRKACA PRKACG HP1BP3 CCNB1	9.52e-06	432	60	7	23455922
Pubmed	CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system.	ZNF462 FANCB LIAS CCDC146 ABCC11 SAMD3 ZUP1	1.07e-05	440	60	7	35156780
Pubmed	Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex.	NCOR2 AHR	1.75e-05	4	60	2	10395741
Pubmed	Protein kinase A-induced phosphorylation of the p65 subunit of nuclear factor-kappaB promotes Schwann cell differentiation into a myelinating phenotype.	PRKACA PRKACG	1.75e-05	4	60	2	18385332
Pubmed	The integral membrane protein ITM2A, a transcriptional target of PKA-CREB, regulates autophagic flux via interaction with the vacuolar ATPase.	ATP6V0A4 PRKACA	1.75e-05	4	60	2	25951193
Pubmed	Rap1GAP2 is a new GTPase-activating protein of Rap1 expressed in human platelets.	PRKACA PRKACG	1.75e-05	4	60	2	15632203
Pubmed	A humble hexose monophosphate pathway metabolite regulates short- and long-term control of lipogenesis.	PRKACA PRKACG	1.75e-05	4	60	2	12721358
Pubmed	The silencing mediator of retinoic acid and thyroid hormone receptors can interact with the aryl hydrocarbon (Ah) receptor but fails to repress Ah receptor-dependent gene expression.	NCOR2 AHR	1.75e-05	4	60	2	12139968
Pubmed	Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.	SMCHD1 SUPT16H CSTF3 NUP188 SNRPB2 HP1BP3	2.68e-05	340	60	6	29478914
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	GTF3C1 SMCHD1 SUPT16H PRKACG NUP188 HP1BP3	2.73e-05	341	60	6	32971831
Pubmed	HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling.	PRKACA PRKACG	2.92e-05	5	60	2	12972513
Pubmed	Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.	PRKACA PRKACG	2.92e-05	5	60	2	19483721
Pubmed	HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction.	PRKACA PRKACG	2.92e-05	5	60	2	21745501
Pubmed	Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts.	PRKACA PRKACG	2.92e-05	5	60	2	9540970
Pubmed	PKA-mediated stabilization of FoxH1 negatively regulates ERalpha activity.	PRKACA PRKACG	2.92e-05	5	60	2	19711044
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	LIAS APPBP2 GTF3C1 AHR GNAT3 NUP188 SAMD3 DNAH14	3.75e-05	736	60	8	29676528
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	ZNF462 NCOR2 SMCHD1 SUPT16H CSTF3	3.98e-05	220	60	5	35785414
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	NCOR2 ST6GAL2 MBTD1 PRTG TRANK1 RBM5 NUP188 DNAH14 HEPH CCDC33	4.02e-05	1215	60	10	15146197
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF462 CABLES2 NCOR2 GTF3C1 MCM8 PTBP2 RBM5 CSTF3 NAALADL2 DNAH14 HP1BP3	4.24e-05	1489	60	11	28611215
Pubmed	Architectural DNA-binding properties of the spermatidal transition proteins 1 and 2.	PRKACA PRKACG	4.37e-05	6	60	2	9837753
Pubmed	Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation.	PRKACA PRKACG	4.37e-05	6	60	2	19197368
Pubmed	Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.	NCOR2 CCNB1	4.37e-05	6	60	2	22508987
Pubmed	Mitotic phosphorylation prevents the binding of HMGN proteins to chromatin.	PRKACA PRKACG	6.11e-05	7	60	2	11438671
Pubmed	Dynamic binding of PKA regulatory subunit RI alpha.	PRKACA PRKACG	6.11e-05	7	60	2	16407073
Pubmed	Phosphorylation of HIV Nef by cAMP-dependent protein kinase.	PRKACA PRKACG	6.11e-05	7	60	2	15629779
Pubmed	BCAS2 regulates oocyte meiotic prophase I by participating in mRNA alternative splicing.	MCM8 GOLGA8H TEX15	6.15e-05	44	60	3	38085152
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	NCOR2 MBTD1 GTF3C1 SMCHD1 SUPT16H RBM5 NUP188 IFI16 SNRPB2 HP1BP3	6.80e-05	1294	60	10	30804502
Pubmed	Ikaros-CtIP interactions do not require C-terminal binding protein and participate in a deacetylase-independent mode of repression.	HDAC9 NCOR2	8.14e-05	8	60	2	11959865
Pubmed	HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism.	PRKACA PRKACG	8.14e-05	8	60	2	1978848
Pubmed	CCL3L1 prevents gp120-induced neuron death via the CREB cell signaling pathway.	PRKACA PRKACG	8.14e-05	8	60	2	19100722
Pubmed	HIV Gag p17 protein impairs proliferation of normal lymphocytes in vitro.	PRKACA PRKACG	8.14e-05	8	60	2	7946090
Pubmed	Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).	PRKACA PRKACG	8.14e-05	8	60	2	12628924
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ZNF462 SLC25A18 GTF3C1 PTBP2 SUPT16H RBM5 CSTF3 SNRPB2 HP1BP3	9.39e-05	1082	60	9	38697112
Pubmed	Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo.	HDAC9 NCOR2	1.05e-04	9	60	2	11466315
Pubmed	Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes.	PRKACA PRKACG	1.05e-04	9	60	2	7688126
Pubmed	Ellis-van Creveld Syndrome	PRKACA WDR35	1.05e-04	9	60	2	37903214
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	FANCB GTF3C1 SMCHD1 RBM5 CSTF3 IFI16	1.31e-04	453	60	6	29656893
Pubmed	HIV-1 Tat-peptide inhibits protein kinase C and protein kinase A through substrate competition.	PRKACA PRKACG	1.31e-04	10	60	2	20433920
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	GLMN GTF3C1 SMCHD1 SUPT16H PRKACA RBM5 CSTF3 NUP188 HARS1 SNRPB2	1.50e-04	1425	60	10	30948266
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	ZNF462 GTF3C1 SMCHD1 SUPT16H USP16 CCNB1	1.58e-04	469	60	6	27634302
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	PPP1R2 PHKA2 CABLES2 NCOR2 GTF3C1 SUPT16H NUP188 CCNB1	1.64e-04	910	60	8	36736316
Pubmed	Analysis of BCL6-interacting proteins by tandem mass spectrometry.	HDAC9 NCOR2 WDR35	1.72e-04	62	60	3	16147992
Pubmed	PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.	PRKACA PRKACG	1.91e-04	12	60	2	10830164
Pubmed	Investigation of genetic susceptibility factors for human longevity - a targeted nonsynonymous SNP study.	ST6GAL2 MANBA MCM8 TLR6 HP1BP3	2.08e-04	313	60	5	20800603
Pubmed	Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.	PRKACA PRKACG	2.26e-04	13	60	2	18836454
Pubmed	Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children.	PRKACA PRKACG	2.26e-04	13	60	2	19895210
Pubmed	MCM8 interacts with DDX5 to promote R-loop resolution.	MCM8 CCNB1	2.26e-04	13	60	2	38858601
Pubmed	The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells.	PRKACA PRKACG	2.26e-04	13	60	2	20402410
Pubmed	Protein kinase A phosphorylation activates Vpr-induced cell cycle arrest during human immunodeficiency virus type 1 infection.	PRKACA PRKACG	2.26e-04	13	60	2	20392842
Pubmed	Proximity labeling reveals OTUD3 as a DNA-binding deubiquitinase of cGAS.	WDR35 RBM5 HP1BP3	2.26e-04	68	60	3	36966392
Pubmed	IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis.	AHR TLR6	2.63e-04	14	60	2	23853597
Pubmed	Interactions of the Antiviral Factor Interferon Gamma-Inducible Protein 16 (IFI16) Mediate Immune Signaling and Herpes Simplex Virus-1 Immunosuppression.	SMCHD1 SUPT16H NUP188 IFI16 HP1BP3	2.73e-04	332	60	5	25693804
Pubmed	cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes.	PRKACA PRKACG	3.03e-04	15	60	2	2165385
Pubmed	A Y2H-seq approach defines the human protein methyltransferase interactome.	TAF1A CCDC74A ECI2 SAMD3 ZUP1	3.13e-04	342	60	5	23455924
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	NCOR2 SMCHD1 NUP188	3.39e-04	78	60	3	28611094
Pubmed	Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.	PRKACA PRKACG	3.91e-04	17	60	2	24189052
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	NCOR2 PTBP2 SMCHD1 SUPT16H	4.26e-04	203	60	4	22083510
Pubmed	Liganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation.	USP16 CCNB1	4.91e-04	19	60	2	26389696
Pubmed	Synapsin and synaptic vesicle protein expression during embryonic and post-natal lens fiber cell differentiation.	PRKACA SYT1	4.91e-04	19	60	2	15529118
Pubmed	Scrg1, a novel protein of the CNS is targeted to the large dense-core vesicles in neuronal cells.	GOLGA8H SYT1	4.91e-04	19	60	2	14622145
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	NCOR2 PTBP2 SMCHD1 CSTF3 SNRPB2 CCNB1	4.98e-04	582	60	6	20467437
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOR2 GTF3C1 SMCHD1 RBM5 CSTF3 IFI16 SNRPB2 CCNB1	5.92e-04	1103	60	8	34189442
Pubmed	DJ-1 associates with synaptic membranes.	GOLGA8H SYT1	6.02e-04	21	60	2	21645620
Pubmed	The human immunodeficiency virus coat protein gp120 promotes forward trafficking and surface clustering of NMDA receptors in membrane microdomains.	PRKACA PRKACG	6.02e-04	21	60	2	22114277
Pubmed	Human immunodeficiency virus Tat protein induces interleukin 6 mRNA expression in human brain endothelial cells via protein kinase C- and cAMP-dependent protein kinase pathways.	PRKACA PRKACG	6.02e-04	21	60	2	9671211
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ZNF462 GTF3C1 PTBP2 SMCHD1 SUPT16H HP1BP3	6.26e-04	608	60	6	36089195
Pubmed	The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix.	PRKACA PRKACG	6.61e-04	22	60	2	9151826
Pubmed	microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart.	PTBP2 CCNB1	6.61e-04	22	60	2	19015276
Pubmed	HIV-1 tat molecular diversity and induction of TNF-alpha: implications for HIV-induced neurological disease.	PRKACA PRKACG	7.23e-04	23	60	2	9730685
Pubmed	Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells.	NCOR2 DLK1	7.23e-04	23	60	2	19737349
Pubmed	The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases.	PRKACA PRKACG	7.23e-04	23	60	2	9278385
Pubmed	The association of innate immune response gene polymorphisms and puerperal group A streptococcal sepsis.	TLR6 ACE	7.23e-04	23	60	2	20207250
Pubmed	Proteomic profiling of the TRAF3 interactome network reveals a new role for the ER-to-Golgi transport compartments in innate immunity.	PRKACA CCDC168	7.23e-04	23	60	2	22792062
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SLC25A18 GTF3C1 PTBP2 FAM186A SMCHD1 SUPT16H PRKACA RBM5 HP1BP3	7.76e-04	1442	60	9	35575683
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	PPP1R2 PHKA2 FANCB GTF3C1 GNAT3 NUP188 SNRPB2 CCNB1	7.99e-04	1155	60	8	20360068
Pubmed	Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex.	SMCHD1 SUPT16H HP1BP3	8.30e-04	106	60	3	19394292
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	PHKA2 SAMD9 GTF3C1 MCM8 GNAT3 HP1BP3	8.86e-04	650	60	6	38777146
Pubmed	Comprehensive proteomic analysis of the human spliceosome.	RBM5 CSTF3 SNRPB2	9.00e-04	109	60	3	12226669
Pubmed	Molecular mechanisms of bitter and sweet taste transduction.	TAS2R13 GNAT3	9.26e-04	26	60	2	11696554
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	SMCHD1 SUPT16H CSTF3 NUP188 SNRPB2 HP1BP3	9.58e-04	660	60	6	32780723
Pubmed	Role of phosphorylation in the nuclear biology of HIV-1.	PRKACA PRKACG	9.99e-04	27	60	2	21651489
Pubmed	Developmental gene expression profiling along the tonotopic axis of the mouse cochlea.	ATP6V0A4 CCNB1	1.07e-03	28	60	2	22808246
Pubmed	Notch signaling in stomach epithelial stem cell homeostasis.	CBLIF DLK1	1.15e-03	29	60	2	21402740
Pubmed	Isolation and characterization of proteins associated with histone H3 tails in vivo.	HDAC9 SUPT16H	1.23e-03	30	60	2	17403666
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	NCOR2 PTBP2 SMCHD1 SUPT16H CSTF3 SYT1 HP1BP3	1.25e-03	954	60	7	36373674
Pubmed	The protein interaction landscape of the human CMGC kinase group.	PPP1R2 CABLES2 SUPT16H PRKACA NUP188 CCNB1	1.25e-03	695	60	6	23602568
Pubmed	Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.	HDAC9 PHKA2	1.32e-03	31	60	2	14684825
Pubmed	Glucagon and regulation of glucose metabolism.	PRKACA PRKACG	1.32e-03	31	60	2	12626323
Pubmed	The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.	SMCHD1 CSTF3 SNRPB2 CCNB1	1.43e-03	281	60	4	24163370
Pubmed	KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4.	PPP1R2 NCOR2 IFI16	1.49e-03	130	60	3	35545047
Coexpression	PARENT_MTOR_SIGNALING_UP	LIAS SAMD9 TRANK1 GTF3C1 RBM5 SYT1 ECI2 NUP188 IFI16	5.39e-06	567	60	9	M16909
ToppCell	severe_COVID-19-HSPC\|severe_COVID-19 / disease group, cell group and cell class (v2)	ZNF462 ST6GAL2 PRTG ABCC11 DLK1 NAALADL2	1.29e-07	174	60	6	6d35bacf073537b272ff821e604c899fb9ce6a7c
ToppCell	VE\|World / Condition, Cell_class and T cell subcluster	SAMD9 TRANK1 SMCHD1 SAMD3 IFI16 HP1BP3	2.93e-07	200	60	6	8ae7cb81de3ffac5acdf3466d4b516d80cac95d3
ToppCell	COVID-19_Moderate-NK_activated\|World / disease group, cell group and cell class	SAMD9 TRANK1 CCDC146 SAMD3 IFI16	5.20e-06	186	60	5	ff8f32f69516bf785224fa12f8139a95359b0279
ToppCell	Mild-CD8+_T_activated\|World / Disease group and Cell class	SAMD9 TRANK1 SMCHD1 SAMD3 IFI16	6.70e-06	196	60	5	79632190e44fcef9d7c11d9b9e37f2ebf0e6e255
ToppCell	CV-Moderate-1\|CV / Virus stimulation, Condition and Cluster	SAMD9 TRANK1 SMCHD1 SAMD3 IFI16	6.87e-06	197	60	5	e3d00d850b4d191f9592ef993c0eaadfe5710b5f
ToppCell	Mild-CD8+_T_activated\|Mild / Disease group and Cell class	SAMD9 TRANK1 SMCHD1 SAMD3 IFI16	7.04e-06	198	60	5	ceac1b51bacfd0dd7fe7c6a666f7927055e1f380
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF462 PRTG ATP6V0A4 DLK1	7.42e-05	166	60	4	37794a84601a2a949d579663d4a4bb8bc8fb5923
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF462 PRTG ATP6V0A4 DLK1	7.42e-05	166	60	4	81c546c6d847e49e662b81e71992ca0f7a99e890
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ST6GAL2 CCDC168 SAMD3 DNAH14	8.90e-05	174	60	4	ae363ce736fc8af439f3ad594d7bc2e344db80d4
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ST6GAL2 CCDC168 SAMD3 DNAH14	9.30e-05	176	60	4	40993c41c1017b53039a337174fc56632b278609
ToppCell	severe_COVID-19-HSPC\|World / disease group, cell group and cell class (v2)	ST6GAL2 ABCC11 DLK1 NAALADL2	9.51e-05	177	60	4	289f6aed6f054b04b01659434d8c8b467d1bf5dd
ToppCell	T_cells-ISG-high_CD4+_T_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	SAMD9 TRANK1 SMCHD1 IFI16	9.93e-05	179	60	4	af35ef8a7768cee0c2af0590e5bec35cee6a4714
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	SAMD9 TRANK1 SMCHD1 IFI16	1.08e-04	183	60	4	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	COVID-19_Severe-CD8+_T_activated\|COVID-19_Severe / Disease condition and Cell class	SAMD9 CCDC146 SAMD3 IFI16	1.15e-04	186	60	4	fc087b79240fe7ada5810d4f4b3c7287eab598ff
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated\|COVID-19_Severe / Disease group, lineage and cell class	SAMD9 CCDC146 SAMD3 IFI16	1.17e-04	187	60	4	4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c
ToppCell	T_cells-ISG-high_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	SAMD9 TRANK1 SMCHD1 IFI16	1.20e-04	188	60	4	6f8946d4710f6e32c937213f99b790b098b8819c
ToppCell	(7)_DC_1\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ZNF462 CCDC74A AHR ABCC11	1.20e-04	188	60	4	832887afa4a54ed80906bc02176d646529c13398
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SAMD9 CCDC146 SAMD3 IFI16	1.25e-04	190	60	4	b9182c84e44aa31684b5388cf3ef4fd1b9e51de4
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SAMD9 CCDC146 SAMD3 IFI16	1.25e-04	190	60	4	88c092a5e78ccaddf406f8fff74376bb761b9790
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SAMD9 CCDC146 SAMD3 IFI16	1.25e-04	190	60	4	4b42a16902d7d1494f953cc88af1e761e76bdf2c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SAMD9 CCDC146 SAMD3 IFI16	1.25e-04	190	60	4	9501f0995f3d52be90c02b1aa0c7d184bd788c16
ToppCell	Mild/Remission-B_activate-7\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SAMD9 TRANK1 SMCHD1 IFI16	1.27e-04	191	60	4	382686d62f7b8576c44bb9726a4e10dc26fd348e
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	HDAC9 MANBA SMCHD1 WDR35	1.33e-04	193	60	4	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HDAC9 CABLES2 GLMN LIAS	1.35e-04	194	60	4	9a99abc65e7509e7ae8fb392f5ee4b2a83128072
ToppCell	Mild/Remission-B_activate-7\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	SAMD9 TRANK1 SMCHD1 IFI16	1.35e-04	194	60	4	01c97543972159a9468272da06e7e611e2c21fae
ToppCell	B_cells-ISG-high_B_cells\|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis	SAMD9 TRANK1 SMCHD1 IFI16	1.38e-04	195	60	4	b64d9e1a8834401b4dc501566546647754ae21fc
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF462 DLK1 HP1BP3 CCNB1	1.41e-04	196	60	4	8faac7fbdee3a9297023c3151ef1751605413e44
ToppCell	mild-Myeloid-Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SAMD9 TRANK1 SMCHD1 IFI16	1.41e-04	196	60	4	ded44b38ea489946e9eedfe752b5a9fde9149c16
ToppCell	Mild-CD4+_T_activated\|World / Disease group and Cell class	SAMD9 TRANK1 SMCHD1 IFI16	1.41e-04	196	60	4	417b4fc2e4388f34c410576131b02936f93e46b6
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SAMD9 GTF3C1 SAMD3 IFI16	1.41e-04	196	60	4	5b5cf6f70534661d694f47359b6595b4580876c3
ToppCell	Mild-CD4+_T_activated\|Mild / Disease group and Cell class	SAMD9 TRANK1 SMCHD1 IFI16	1.41e-04	196	60	4	daa1c3322d81e649161e889e1d78451d2d425d09
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SAMD9 TRANK1 SMCHD1 IFI16	1.44e-04	197	60	4	0b4fdf0131dd67a86ee3209fa66db0ca2e01a10e
ToppCell	severe-Myeloid-Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	SAMD9 TRANK1 SMCHD1 IFI16	1.44e-04	197	60	4	c8a90d82170cf20e14aebecddcf7cc0ca56cda87
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SAMD9 TRANK1 SMCHD1 IFI16	1.44e-04	197	60	4	b3876076684781fb8384117f2cf367d828985986
ToppCell	systemic_lupus_erythematosus-treated\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SAMD9 SMCHD1 SAMD3 IFI16	1.46e-04	198	60	4	8165ff735095c52994fb5057d89be93cc378b7da
ToppCell	systemic_lupus_erythematosus-flare\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SAMD9 SMCHD1 SAMD3 IFI16	1.46e-04	198	60	4	4c93ee921d56132d80832d8e94563f32ccf13bbc
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SAMD9 TRANK1 SAMD3 IFI16	1.46e-04	198	60	4	ce92d5fbc2eac27fb246b044fb1914ab92506275
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	SAMD9 TRANK1 SAMD3 IFI16	1.46e-04	198	60	4	fed823d6e684d113bcc9ff3cd1803bb001aa02fa
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SAMD9 TRANK1 SAMD3 IFI16	1.46e-04	198	60	4	0e918e9db9b884f5328d438e90efe065e27266ee
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SAMD9 TRANK1 SAMD3 IFI16	1.46e-04	198	60	4	1ef3a6bd681c223eed58300348adfef89df5563c
ToppCell	CV-Mild-1\|CV / Virus stimulation, Condition and Cluster	SAMD9 TRANK1 SMCHD1 IFI16	1.46e-04	198	60	4	4b078714c49e7befb7b113d72485e712236d35fa
ToppCell	COVID-19_Severe-Lymphoid_T/NK-NK_activated\|COVID-19_Severe / Disease group, lineage and cell class	SAMD9 TRANK1 SAMD3 IFI16	1.49e-04	199	60	4	edf5f80b4c299e6bf462675f2cd3329d86c923d8
ToppCell	VE-CD4-antiviral_CD4\|VE / Condition, Cell_class and T cell subcluster	SAMD9 TRANK1 SMCHD1 IFI16	1.49e-04	199	60	4	056a0538ca5e825ae6195b4c76c208708a014533
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SMCHD1 AHR ACE IFI16	1.52e-04	200	60	4	b7533c571eeea0cb3678e1a57d3dc036fa8d0f49
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SMCHD1 AHR ACE IFI16	1.52e-04	200	60	4	a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 TRANK1 SMCHD1 SAMD3	1.52e-04	200	60	4	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated\|COVID-19_Severe / Disease, condition lineage and cell class	SAMD9 TRANK1 SAMD3 IFI16	1.52e-04	200	60	4	6a77f9643646bafc1157bf1fc1e4c614860ee642
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	SAMD9 TRANK1 SAMD3 IFI16	1.52e-04	200	60	4	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SMCHD1 AHR ACE IFI16	1.52e-04	200	60	4	bcd1cc96197929d6011903803b6f4ccdcf52b4ce
ToppCell	LPS_IL1RA_TNF-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SMCHD1 AHR ACE IFI16	1.52e-04	200	60	4	d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCell	Control_saline-Endothelial-Endothelial-Activated_Alv_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	SMCHD1 AHR ACE IFI16	1.52e-04	200	60	4	be55cef682ba87250dad97689332c8820b3a7420
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	SMCHD1 AHR ACE IFI16	1.52e-04	200	60	4	432384faeade8e609154fab3d96c955a8ec868dd
ToppCell	Sepsis-Int-URO-Myeloid-cDC1\|Int-URO / Disease, condition lineage and cell class	ZNF462 HDAC9 CCDC74A SUPT16H	1.52e-04	200	60	4	77479f733cc4ce62a07ab33d5dc2d41c911c74fc
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_T_activated\|COVID-19_Severe / Disease, condition lineage and cell class	SAMD9 CCDC146 SAMD3 IFI16	1.52e-04	200	60	4	b7f80b2db07119069fbf3d245cf1ad79e8648bab
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SMCHD1 AHR ACE IFI16	1.52e-04	200	60	4	89821a264e872ed53e08e9d3609d5cc5c314503e
ToppCell	Sepsis-URO-Myeloid-cDC1\|URO / Disease, condition lineage and cell class	ZNF462 HDAC9 CCDC74A IFI16	1.52e-04	200	60	4	c5ca81218be40b30e2f9252c1a004cb95d988447
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SMCHD1 AHR ACE IFI16	1.52e-04	200	60	4	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SMCHD1 AHR ACE IFI16	1.52e-04	200	60	4	66f7e8ee63c828f17468e79a4b816346b33e8980
Drug	rhodamine B base	AHR ACE	6.83e-06	2	60	2	CID000062357
Drug	2,4-dimethyl-2-eicosenoic acid	FANCB DLK1	6.83e-06	2	60	2	CID005282673
Disease	cleft lip	NCOR2 PRTG ERCC6L2 DLK1 CCDC168 NAALADL2	2.01e-05	284	58	6	EFO_0003959
Disease	Male sterility	AHR GNAT3 ACE	1.17e-04	48	58	3	C0917731
Disease	Male infertility	AHR GNAT3 ACE	1.17e-04	48	58	3	C0021364
Disease	Subfertility, Male	AHR GNAT3 ACE	1.17e-04	48	58	3	C0848676
Disease	MYELODYSPLASTIC SYNDROME	FANCB SAMD9 DLK1	3.16e-04	67	58	3	C3463824
Disease	Non-alcoholic Fatty Liver Disease	PRKACA AHR ACE	3.59e-04	70	58	3	C0400966
Disease	Nonalcoholic Steatohepatitis	PRKACA AHR ACE	3.59e-04	70	58	3	C3241937
Disease	Craniosynostosis	ZNF462 WDR35	7.05e-04	20	58	2	C0010278
Disease	Fetal Growth Retardation	SAMD9 DLK1	7.05e-04	20	58	2	C0015934
Disease	Left Ventricular Hypertrophy	AHR ACE	1.11e-03	25	58	2	C0149721
Disease	Hematopoetic Myelodysplasia	SAMD9 DLK1	1.49e-03	29	58	2	C2713368
Disease	lymphocyte percentage of leukocytes	PPP1R2 HDAC9 GLMN MANBA GTF3C1 IFI16	1.92e-03	665	58	6	EFO_0007993

Protein segments in the cluster

Peptide	Gene	Start	Entry
AMNFQGKLKYLHGQK	AHR	236	P35869
QAALLKQYQGKLQKM	CCDC33	736	Q8N5R6
LLQKNMQIANHTLKY	ACE	686	P12821
TYMDKLSKHGQQANK	APPBP2	191	Q92624
HMLRKKKNLLLQYNS	DLK1	341	P80370
HYKLIMNQTSQKKDG	CCDC74A	86	Q96AQ1
NSNYQMHLLKKTLQK	HP1BP3	376	Q5SSJ5
YHENIKINQAMRKKL	NCOR2	266	Q9Y618
TGNHYAMKILDKQKV	PRKACA	66	P17612
KQMKIIHKNGYSEQE	GNAT3	51	A8MTJ3
SQQYKGHKKMTTLQL	MBTD1	581	Q05BQ5
HYNKAKTVSENLKMG	MCM8	566	Q9UJA3
NKYEEGINIHLAKKM	CSTF3	191	Q12996
HSELMQKKGKYAQLI	ABCC11	716	Q96J66
MGKNYNKLKNTLRNL	LIAS	86	O43766
QKKLVIQGKHIAMHY	RBM5	161	P52756
EMKRKLHYNEGLNIK	PPP1R2	141	P41236
KIHSNGRIKMYNSKL	PRTG	366	Q2VWP7
KKMLQTNLKVSGALY	FANCB	821	Q8NB91
NQGLTKHMTVKNKYA	CCNB1	391	P14635
MNLAGAYNLKAQKLL	CBLIF	61	P27352
TGGHYAMKILNKQKV	PRKACG	66	P22612
LAKTRLQNQHGKAMY	SLC25A18	31	Q9H1K4
KMGNKYLQRTGVNLK	DNAH14	3036	Q0VDD8
GNKQMLYQAGLHFKL	MANBA	591	O00462
QKGKLNTDLYHMKRS	GOLGA8H	141	P0CJ92
VYGVFMLHKKTVNQK	IFI16	316	Q16666
NRPKKKNAINTEMYH	ECI2	156	O75521
SHKVILKANQQMPYK	CCDC168	4866	Q8NDH2
KYSGKMKVLQQLLNH	ERCC6L2	516	Q5T890
GQKRNQCLKKMIHVF	FAM186A	2216	A6NE01
KQYQQQIHMNKLLSK	HDAC9	476	Q9UKV0
NHTIYINNMNDKIKK	SNRPB2	6	P08579
MNKLTNIKRYHIAKV	HARS1	141	P12081
KGLKKTHFIKNMRQY	CABLES2	156	Q9BTV7
HIYAKLGRNKNMNLS	PHKA2	481	P46019
AMLQLYINKLDSQGK	GLMN	386	Q92990
PYVKIHLMQNGKRLK	SYT1	311	P21579
QKHLQKMQLNYKGHR	TAS2R13	206	Q9NYV9
FKKMENIQKLGNYTL	SMCHD1	776	A6NHR9
AMNHLNGQKMYGKII	PTBP2	391	Q9UKA9
GHQAVLMDLIKKYKQ	SAMD3	51	Q8N6K7
LMDLIKKYKQNTQGL	SAMD3	56	Q8N6K7
LKKSYHLNKSQIMLD	SAMD9	996	Q5K651
KNIGVMNYLKISLQH	TAF1A	126	Q15573
SNKMHAINGKLYANL	HEPH	961	Q9BQS7
LQKAMKDYLTANKHG	ST6GAL2	221	Q96JF0
LVINSKNQYKLKKGM	SUPT16H	361	Q9Y5B9
KQDTLLLAKKMNGYQ	CCDC146	796	Q8IYE0
GERKHVYTNAKKQML	USP16	671	Q9Y5T5
KMLQHYLQNKNGDGL	NUP188	1496	Q5SRE5
QNSIPNKYHKLKALM	TLR6	741	Q9Y2C9
ALILYHNKLKQGQSM	TMEM225	116	Q6GV28
LIKVQKMKAVYHILN	ATP6V0A4	296	Q9HBG4
LRKSMGNLKHKQYQI	ZUP1	536	Q96AP4
QKMYHKNNLKETTAP	ZNF462	181	Q96JM2
KLMELKLGKINQNYA	TEX15	361	Q9BXT5
QLVKYMNSGNRLLHK	TRANK1	336	O15050
YHRKILNKNGLITMQ	GTF3C1	211	Q12789
YHEQMKNAQRGKVKG	WDR35	981	Q9P2L0
TSLQGKKMAYQKVHA	NAALADL2	11	Q58DX5